Download PDF
Thromb Haemost 1978; 40(02): 377-386
DOI: 10.1055/s-0038-1648671
Original Article
Schattauer GmbH Stuttgart

Studies on the Effect of Plasminogen Activator on the Interaction between α2-Macroglobulin and Plasmin

Naotika Toki
*   The Department of Dermatology, Hiroshima University School of Medicine, Hiroshima, japan
,
Sumiyoshi Takasugi
**   The Department of Surgery, Hiroshima University School of Medicine, Hiroshima, japan
,
Hiroyuki Sumi
***   The Department of Physiology, Hamamatu University School of Medicine, Hamamatu, Japan
,
Takuso Yamura
*   The Department of Dermatology, Hiroshima University School of Medicine, Hiroshima, japan
› Author Affiliations
Further Information

Publication History

Received 25 February 1978

Accepted 22 March 1978

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Six different plasmins were prepared by incubating human plasminogen with various amounts of streptokinase or urokinase. It was confirmed that the six different plasmins possessed similar caseinolytic activities, and the inhibitory effects of α 1-antitrypsin on caseinolytic activities of the six different plasmins were all the same. On the other hand, interactions between the six different plasmins and α2-macroglobulin were complicated. Plasmins activated by cleavage of plasminogen were almost immediately or effectively inhibited by α2-macroglobulin. However, plasmin activated by complex formation of plasminogen with streptokinase was not so immediately or effectively inhibited by α2- macroglobulin. It was supposed that the difference between these two results on the interaction between plasmin and α2-macroglobulin might be due to the difference in molecular form of plasmin. In the present study, it was also confirmed that streptokinase or urokinase, in free form in the reaction mixture, interfered with the interaction between plasmin and α2-macroglobulin. The cause for such interference was discussed.

 

  • References

  • 1 Ambrus CM, Markus G. 1960; Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. American Journal of Physiology 199: 491
    PubMedGoogle Scholar
  • 2 Bell WR. 1976; Streptokinase and urokinase in the treatment of pulmonary thromboemboli. Thrombosis and Haemostasis (Stuttg.) 35: 57
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Ganrot PO. 1976; Inhibition of plasmin activity by α2-macroglobulin. Clinica et Chimica Acta 16: 328
    PubMedGoogle Scholar
  • 4 Haines AL, Lepow IH. 1964; Studies on human CI esterase. I. Purification and enzymatic properties. Journal of Immunology 92: 456
    PubMedGoogle Scholar
  • 5 Harpel PC, Mosesson MW. 1973; Degradation of human fibrinogen by plasma α2- macroglobulin-enzyme complexes. Journal of Clinical Investigation 52: 2175
    CrossrefPubMedGoogle Scholar
  • 6 Hoepfinger LM, Mertz ET. 1969; Studies on plasminogen. VII. Mechanism of activation of bovine plasminogen. Canadian Journal of Biochemistry 47: 909
    CrossrefPubMedGoogle Scholar
  • 7 Ishihara H, Toki N, Yamura T. 1974; Measurement of plasminogen and two antiplasmins by L-Lysine Sepharose affinity chromatography. Hiroshima Journal of medical Science 23: 237
    PubMedGoogle Scholar
  • 8 Iwamoto M. 1975; Plasminogen-plasmin system. IX. Specific binding of tranexamic acid to plasmin. Thrombosis et Diathesis Haemorrhagica (Stuttg.) 33: 73
    PubMedGoogle Scholar
  • 9 Lieu TH, Mertz ET. 1971; Studies on plasminogen. IX. Purification of human plasminogen from Cohn Fraction III by affinity chromatography. Canadian Journal of Biochemistry 49: 1055
    CrossrefPubMedGoogle Scholar
  • 10 Lowry OH, Farr AL, Randall RJ. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265
    PubMedGoogle Scholar
  • 11 Mullertz S, Lassen M. 1953; An activator system in blood indispensable for formation of plasmin by streptokinase. Proceedings of the Society for Experimental Biology and Medicine 82: 264
    PubMedGoogle Scholar
  • 12 Muramatu M, Onishi T, Fujii S. 1965; Inhibition of caseinolytic activity of plasmin by various synthetic inhibitors. Journal of Biochemistry 57: 402
    PubMedGoogle Scholar
  • 13 Muramatu M, Onishi T, Sato T, Fujii S. 1968; Interaction of streptokinase with human plasminogen. Journal of Biochemistry 64: 87
    PubMedGoogle Scholar
  • 14 Muramatu M, Hayakumo Y, Onishi T, Sato T, Fujii S. 1969; Comparison of human plasmins formed by activation with trace and large amounts of streptokinase. Journal of Biochemistry 65: 329
    PubMedGoogle Scholar
  • 15 Norman PS. 1957; Effect of urea and methylamine on plasmin. Proceedings of the Society for Experimental Biology and Medicine 96: 709
    PubMedGoogle Scholar
  • 16 Norman PS. 1958; Studies on the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. Journal of Experimental Medicine 109: 639
    PubMedGoogle Scholar
  • 17 Ogston D, Bennet B, Herbert RJ, Douglas AS. 1973; The inhibition of urokinase by alpha2-macroglobulin. Clinical Science 44: 73
    CrossrefPubMedGoogle Scholar
  • 18 Prentice CR M, Turpie AG G, Mcnicol GP, Douglas AS. 1972; Urokinase therapy: Dosage schedules and coagulant side effects. British Journal of Haematology 22: 567
    CrossrefPubMedGoogle Scholar
  • 19 Robbins KC, Summaria L, Hsieh B, Shah RJ. 1967; The peptide chains of human plasmin. Mechanisms of activation of human plasminogen to plasmin Journal of Biological Chemistry 242: 2333
    PubMedGoogle Scholar
  • 20 Steinbuch M, Quetin M, Pajaudier L. 1965; Specific technique for the isolation of human α2- macroglobulin. Nature 205: 1227
    CrossrefPubMedGoogle Scholar
  • 21 Steinbuch M, Blatrix C, Drouet J, Amouch P. 1972; Study of the α2-macroglobulin/ plasmin interaction mechanism. Pathology and Biology 20 (Suppl.) 52
    PubMedGoogle Scholar
  • 22 Steinbuch M, Friess A, Drouet J, Amouch P. 1975; Absence of interaction between streptokinase/plasmin(ogen) complexes and α2-macroglobulin (α2-M). (Abst.) Thrombosis et Diathesis Haemorrhagica 34 (03) 922
    PubMedGoogle Scholar
  • 23 Summaria L, Hsieh L, Robbins KC. 1967; The specific mechanism of activation of human plasminogen to plasmin. Journal of Biological Chemistry 242: 4279
    PubMedGoogle Scholar
  • 24 Tibbutt DA, Davies JA, Anderson JA, Fletcher EW L, Hamill J, Holt JM, Thomas ML, Lee GJ, Miller GA H, Sharp AA, Sutton GC. 1974; Comparison by controlled clincial trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. British Medical Journal 1: 343
    CrossrefPubMedGoogle Scholar
  • 25 Toki N, Ishihara H, Yamura T. 1977; Prevention of plasmin autodigestion by human plasma α2-macroglobulin. Scandinavian Journal of Haematology 19: 281
    PubMedGoogle Scholar